Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
pilocarpinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Poisoning by pilocarpine |
Causative agent |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Accidental pilocarpine poisoning |
Causative agent |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Intentional pilocarpine poisoning |
Causative agent |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
forgiftning med pilocarpin, uvist med hvilken hensigt |
Causative agent |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Allergy to pilocarpine (finding) |
Causative agent |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Accidental pilocarpine overdose |
Causative agent |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 5 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride 20 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride 30 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride 40 mg/g eye gel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride [oropharyngeal] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 5 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride 1 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 0,5 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 1 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 2 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 3 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 4 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride 60 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 6 % øjendråber uden konserveringsmiddel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride 80 mg/mL eye drops |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 1 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 4 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % + pilocarpinhydrochlorid 6 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat 1 % wt/vol + pilocarpinhydrochlorid 2 % wt/vol opløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
pilocarpinhydrochlorid 10 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
adrenalinbitartrat + pilocarpinhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
|
Pilocarpine hydrochloride 20 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 20 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 40 mg/g eye gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 40 mg/g eye gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 60 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 60 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 80 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 80 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 1 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 1 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 5 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 5 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 10 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 30 mg/mL eye drops |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Pilocarpine hydrochloride 30 mg/mL eye drops |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye drops (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye drops (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 80 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 2.5 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 100 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Physostigmine salicylate 2.5 mg/mL and pilocarpine hydrochloride 20 mg/mL eye solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely physostigmine salicylate 5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely physostigmine salicylate 2.5 milligram/1 milliliter and pilocarpine hydrochloride 40 milligram/1 milliliter conventional release eye solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely pilocarpine hydrochloride 7.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Pilocarpine hydrochloride (substance) |
Inferred relationship |
Some |
1 |